Cardiovascular disease prevention tailored for women

References

• Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation117(4), e25–e146 (2008).
   PubMed Web of Science ®Google Scholar
• Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet339(8795), 702–706 (1992).
   PubMed Web of Science ®Google Scholar
• Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J.111(2), 383–390 (1986).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch. Intern. Med.155(1), 57–61 (1995).
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T et al.; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA280(7), 605–613 (1998).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA288(3), 321–333 (2002).
   PubMed Web of Science ®Google Scholar
• Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart Lung, and Blood Institute. N. Engl. J. Med.343(7), 475–480 (2000).
   PubMed Web of Science ®Google Scholar
• Blauwet LA, Redberg RF. The role of sex-specific results reporting in cardiovascular disease. Cardiol. Rev.15(6), 275–278 (2007).
   PubMedGoogle Scholar
• Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch. Intern. Med.163(17), 2006–2010 (2003).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med.352(13), 1293–1304 (2005).
   PubMed Web of Science ®Google Scholar
• Mosca L, Appel LJ, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation109(5), 672–693 (2004).
   PubMed Web of Science ®Google Scholar
• Mosca L, Banka CL, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation115(11), 1481–1501 (2007).
   PubMed Web of Science ®Google Scholar
• Mosca L, Grundy SM, Judelson D et al. Guide to preventive cardiology for women. AHA/ACC Scientific Statement Consensus panel statement. Circulation99(18), 2480–2484 (1999).
   PubMed Web of Science ®Google Scholar
• Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog. Cardiovasc. Dis.46(3), 199–229 (2003).
   PubMed Web of Science ®Google Scholar
• Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J. Am. Coll. Cardiol.50(22), 2128–2132 (2007).
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care27(10), 2444–2449 (2004).
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care29(3), 625–630 (2006).
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Manson JE et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N. Engl. J. Med.343(8), 530–537 (2000).
   PubMed Web of Science ®Google Scholar
• Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA282(21), 2012–2018 (1999).
   PubMed Web of Science ®Google Scholar
• Greenland P, Knoll MD, Stamler J et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA290(7), 891–897 (2003).
   PubMed Web of Science ®Google Scholar
• Khot UN, Khot MB, Bajzer CT et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA290(7), 898–904 (2003).
   PubMed Web of Science ®Google Scholar
• Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch. Intern. Med.158(18), 2007–2014 (1998).
   PubMed Web of Science ®Google Scholar
• Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation99(9), 1165–1172 (1999).
   PubMed Web of Science ®Google Scholar
• Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J. Cardiovasc. Risk9(2), 67–76 (2002).
   PubMedGoogle Scholar
• Daviglus ML, Stamler J, Pirzada A et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA292(13), 1588–1592 (2004).
   PubMed Web of Science ®Google Scholar
• Matthews KA, Kuller LH, Chang Y, Edmundowicz D. Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the healthy women study. Prev. Med.45(4), 302–308 (2007).
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation104(10), 1108–1113 (2001).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA294(3), 326–333 (2005).
   PubMed Web of Science ®Google Scholar
• Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch. Intern. Med.153(19), 2209–2216 (1993).
   PubMed Web of Science ®Google Scholar
• Shai I, Rimm EB, Hankinson SE et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation110(18), 2824–2830 (2004).
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Schaefer EJ, Contois JH et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA298(7), 776–785 (2007).
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation106(25), 3143–3421 (2002).
   PubMed Web of Science ®Google Scholar
• Screening adults for lipid disorders: recommendations and rationale. Am. J. Prev. Med.20(3 Suppl.), 73–76 (2001).
   PubMedGoogle Scholar
• Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N. Engl. J. Med.339(1), 12–20 (1998).
   PubMed Web of Science ®Google Scholar
• Kraus WE, Houmard JA, Duscha BD et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med.347(19), 1483–1492 (2002).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann. Epidemiol.2(1–2), 161–176 (1992).
   PubMedGoogle Scholar
• Criqui MH, Heiss G, Cohn R et al. Plasma triglyceride level and mortality from coronary heart disease. N. Engl. J. Med.328(17), 1220–1225 (1993).
   PubMed Web of Science ®Google Scholar
• Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA288(23), 2998–3007 (2002).
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet360(9346), 1623–1630 (2002).
   PubMed Web of Science ®Google Scholar
• Downs JR, Clearfield M, Weis S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas coronary atherosclerosis prevention study. JAMA279(20), 1615–1622 (1998).
   PubMed Web of Science ®Google Scholar
• Sever PS, Dahlof B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet361(9364), 1149–1158 (2003).
   PubMed Web of Science ®Google Scholar
• Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med.333(20), 1301–1307 (1995).
   PubMed Web of Science ®Google Scholar
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet360(9326), 7–22 (2002).
   PubMed Web of Science ®Google Scholar
• Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in Type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet364(9435), 685–696 (2004).
   PubMed Web of Science ®Google Scholar
• Cannon CP, Braunwald E, McCabe CH et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med.350(15), 1495–1504 (2004).
   PubMed Web of Science ®Google Scholar
• LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med.352(14), 1425–1435 (2005).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation110(2), 227–239 (2004).
   PubMed Web of Science ®Google Scholar
• Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA291(18), 2243–2252 (2004).
   PubMed Web of Science ®Google Scholar
• Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart94(4), 434–439 (2008).
   PubMed Web of Science ®Google Scholar
• Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am. Heart J.152(5), 976–981 (2006).
   PubMedGoogle Scholar
• Colditz GA, Bonita R, Stampfer MJ et al. Cigarette smoking and risk of stroke in middle-aged women. N. Engl. J. Med.318(15), 937–941 (1988).
   PubMed Web of Science ®Google Scholar
• Willett WC, Green A, Stampfer MJ et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N. Engl. J. Med.317(21), 1303–1309 (1987).
   PubMed Web of Science ®Google Scholar
• Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch. Intern. Med.154(2), 169–175 (1994).
   PubMedGoogle Scholar
• Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann. Intern. Med.119(10), 992–1000 (1993).
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N. Engl. J. Med.322(4), 213–217 (1990).
   PubMed Web of Science ®Google Scholar
• Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann. Intern. Med.147(3), 149–155 (2007).
   PubMed Web of Science ®Google Scholar
• Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA281(14), 1291–1297 (1999).
   PubMed Web of Science ®Google Scholar
• Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch. Intern. Med.163(14), 1735–1740 (2003).
   PubMedGoogle Scholar
• Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J. Am. Coll. Cardiol.45(9), 1413–1418 (2005).
   PubMed Web of Science ®Google Scholar
• Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ332(7533), 73–78 (2006).
   PubMed Web of Science ®Google Scholar
• Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N. Engl. J. Med.311(15), 953–959 (1984).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association: clinical practice recommendations 2002. Diabetes Care25 (Suppl. 1), S1–S147 (2002).
   Web of Science ®Google Scholar
• Ratner RE. Prevention of Type 2 diabetes in women with previous gestational diabetes. Diabetes Care30(Suppl. 2), S242–S245 (2007).
   PubMedGoogle Scholar
• Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am. J. Obstet. Gynecol.186(4), 751–756 (2002).
   PubMed Web of Science ®Google Scholar
• Levitzky YS, Pencina MJ, D’Agostino RB et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J. Am. Coll. Cardiol.51(3), 264–270 (2008).
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB Sr. Trends in the incidence of Type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation113(25), 2914–2918 (2006).
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Liu K, Colangelo LA et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation115(8), 1004–1011 (2007).
   PubMed Web of Science ®Google Scholar
• Liu S, Willett WC, Stampfer MJ et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am. J. Clin. Nutr.71(6), 1455–1461 (2000).
   PubMed Web of Science ®Google Scholar
• Hu FB. Diet and cardiovascular disease prevention the need for a paradigm shift. J. Am. Coll. Cardiol.50(1), 22–24 (2007).
   PubMed Web of Science ®Google Scholar
• Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care31(7), 1311–1317 (2008).
   PubMed Web of Science ®Google Scholar
• Weinstein AR, Sesso HD, Lee IM et al. Relationship of physical activity vs body mass index with Type 2 diabetes in women. JAMA292(10), 1188–1194 (2004).
   PubMed Web of Science ®Google Scholar
• Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N. Engl. J. Med.351(26), 2694–2703 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation117(13), 1658–1667 (2008).
   PubMed Web of Science ®Google Scholar
• Manson JE, Greenland P, LaCroix AZ et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N. Engl. J. Med.347(10), 716–725 (2002).
   PubMed Web of Science ®Google Scholar
• Mora S, Redberg RF, Cui Y et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA290(12), 1600–1607 (2003).
   PubMed Web of Science ®Google Scholar
• Sui X, LaMonte MJ, Blair SN. Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men. Am. J. Epidemiol.165(12), 1413–1423 (2007).
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA289(19), 2560–2572 (2003).
   PubMed Web of Science ®Google Scholar
• Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch. Intern. Med.149(4), 780–788 (1989).
   PubMedGoogle Scholar
• The ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA288(23), 2981–2997 (2002).
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Anderson G, Psaty BM et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women’s Health Initiative. Hypertension36(5), 780–789 (2000).
   PubMed Web of Science ®Google Scholar
• Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women. Am. J. Epidemiol.126(5), 861–870 (1987).
   PubMed Web of Science ®Google Scholar
• Ness RB, Harris T, Cobb J et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N. Engl. J. Med.328(21), 1528–1533 (1993).
   PubMed Web of Science ®Google Scholar
• Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am. J. Epidemiol.123(1), 48–58 (1986).
   PubMed Web of Science ®Google Scholar
• Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation104(4), 393–398 (2001).
   PubMed Web of Science ®Google Scholar
• Rich-Edwards JW, Manson JE, Stampfer MJ et al. Height and the risk of cardiovascular disease in women. Am. J. Epidemiol.142(9), 909–917 (1995).
   PubMedGoogle Scholar
• Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch. Intern. Med.160(9), 1261–1268 (2000).
   PubMed Web of Science ®Google Scholar
• Mendes de Leon CF, Krumholz HM, Seeman TS et al. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982–1991. Established Populations For The Epidemiologic Studies Of The Elderly. Arch. Intern. Med.158(21), 2341–2348 (1998).
   PubMedGoogle Scholar
• Vaccarino V, McClure C, Johnson BD et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom. Med.70(1), 40–48 (2008).
   PubMed Web of Science ®Google Scholar
• Mallik S, Spertus JA, Reid KJ et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch. Intern. Med.166(8), 876–883 (2006).
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med.341(4), 217–225 (1999).
   PubMed Web of Science ®Google Scholar
• Hu FB, Bronner L, Willett WC et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA287(14), 1815–1821 (2002).
   PubMed Web of Science ®Google Scholar
• Iso H, Kobayashi M, Ishihara J et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation113(2), 195–202 (2006).
   PubMed Web of Science ®Google Scholar
• Burdge G. α-linolenic acid metabolism in men and women: nutritional and biological implications. Curr. Opin. Clin. Nutr. Metab. Care7(2), 137–144 (2004).
   PubMed Web of Science ®Google Scholar
• Albert CM, Oh K, Whang W et al. Dietary α-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation112(21), 3232–3238 (2005).
   PubMed Web of Science ®Google Scholar
• Brouwer IA, Katan MB, Zock PL. Dietary α-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J. Nutr.134(4), 919–922 (2004).
   PubMed Web of Science ®Google Scholar
• Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet354(9177), 447–455 (1999).
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Origasa H, Matsuzaki M et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet369(9567), 1090–1098 (2007).
   PubMed Web of Science ®Google Scholar
• Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group. N. Engl. J. Med.321(3), 129–135 (1989).
   PubMed Web of Science ®Google Scholar
• Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA295(3), 306–313 (2006).
   PubMed Web of Science ®Google Scholar
• Rimm EB, Willett WC, Hu FB et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA279(5), 359–364 (1998).
   PubMed Web of Science ®Google Scholar
• Bonaa KH, Njolstad I, Ueland PM et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med.354(15), 1578–1588 (2006).
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med.354(15), 1567–1577 (2006).
   PubMed Web of Science ®Google Scholar
• Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA294(1), 56–65 (2005).
   PubMed Web of Science ®Google Scholar
• Cook NR, Albert CM, Gaziano JM et al. A randomized factorial trial of vitamins C and E and β carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study. Arch. Intern. Med.167(15), 1610–1618 (2007).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA297(6), 611–619 (2007).
   PubMed Web of Science ®Google Scholar
• Wenger NK. The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women? Nat. Clin. Pract. Cardiovasc. Med.4(7), 366–367 (2007).
   PubMedGoogle Scholar
• Michos ED, Vasamreddy CR, Becker DM et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am. Heart J.150(6), 1276–1281 (2005).
   PubMed Web of Science ®Google Scholar
• D’Agostino RB Sr, Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation117(6), 743–753 (2008).
   PubMed Web of Science ®Google Scholar
• Lee AJ, Price JF, Russell MJ, Smith FB, van Wijk MC, Fowkes FG. Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study. Circulation110(19), 3075–3080 (2004).
   PubMed Web of Science ®Google Scholar
• Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J. Am. Coll. Cardiol.51(10), 997–1002 (2008).
   PubMed Web of Science ®Google Scholar
• Tice JA, Browner W, Tracy RP, Cummings SR. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am. J. Med.114(3), 199–205 (2003).
   PubMedGoogle Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med.342(12), 836–843 (2000).
   PubMed Web of Science ®Google Scholar
• Apple FS, Pearce LA, Chung A, Ler R, Murakami MM. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem.53(5), 874–881 (2007).
   PubMed Web of Science ®Google Scholar
• Raggi P, Shaw LJ, Berman DS, Callister TQ. Gender-based differences in the prognostic value of coronary calcification. J. Womens Health (Larchmt)13(3), 273–283 (2004).
   PubMedGoogle Scholar
• Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff MJ, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J. Am. Coll. Cardiol.52(1), 17–23 (2008).
   PubMed Web of Science ®Google Scholar
• Bellasi A, Lacey C, Taylor AJ et al. Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta- and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am. J. Cardiol.100(3), 409–414 (2007).
   PubMed Web of Science ®Google Scholar
• de Torbal A, Boersma E, Kors JA et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur. Heart J.27(6), 729–736 (2006).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N. Engl. J. Med.311(18), 1144–1147 (1984).
   PubMed Web of Science ®Google Scholar
• CDC. Trends in ischemic heart disease death rates for blacks and whites – United States, 1981–1995. MMWR Morb. Mortal. Wkly Rep.47(44), 945–949 (1998).
   PubMedGoogle Scholar
• CDC. Compressed Mortality File 1979–1998. CDC WONDER On-line Database, compiled from Compressed Mortality File CMF 1968–1988, Series 20, No. 2A, 2000 and CMF 1989–1998, Series 20, No. 2E, 2003. Centers for Disease Control and Prevention, National Center for Health Statistics, USA (2008).
   Google Scholar
• NCHS. National Health and Nutrition Examination Survey Data. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD, USA (2005).
   Google Scholar